These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21342448)

  • 1. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.
    Musat AI; Agni RM; Wai PY; Pirsch JD; Lorentzen DF; Powell A; Leverson GE; Bellingham JM; Fernandez LA; Foley DP; Mezrich JD; D'Alessandro AM; Lucey MR
    Am J Transplant; 2011 Mar; 11(3):500-10. PubMed ID: 21342448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
    Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
    Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts.
    Collins AB; Chicano SL; Cornell LD; Tolkoff-Rubin N; Goes NB; Saidman SL; Farrell ML; Cosimi AB; Colvin RB
    Transplant Proc; 2006 Dec; 38(10):3427-9. PubMed ID: 17175293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation.
    Salah A; Fujimoto M; Yoshizawa A; Yurugi K; Miyagawa-Hayashino A; Sumiyoshi S; Minamiguchi S; Uemoto S; Maekawa T; Haga H
    Liver Transpl; 2014 Feb; 20(2):200-9. PubMed ID: 24470446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond C4d: the ultrastructural appearances of endothelium in ABO-incompatible renal allografts.
    Bröcker V; Pfaffenbach A; Habicht A; Chatzikyrkou C; Kreipe HH; Haller H; Scheffner I; Gwinner W; Zilian E; Immenschuh S; Schwarz A; Horn PA; Heinemann FM; Becker JU
    Nephrol Dial Transplant; 2013 Dec; 28(12):3101-9. PubMed ID: 24081856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of preformed donor-specific antibodies and C4d on early liver allograft function.
    Perera MT; Silva MA; Murphy N; Briggs D; Mirza DF; Neil DA
    Scand J Gastroenterol; 2013 Dec; 48(12):1444-51. PubMed ID: 24131305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
    OʼLeary JG; Demetris AJ; Philippe A; Freeman R; Cai J; Heidecke H; Smith C; Hart B; Jennings LW; Catar R; Everly M; Klintmalm GB; Dragun D
    Transplantation; 2017 Oct; 101(10):2399-2409. PubMed ID: 28665894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts.
    Kozlowski T; Andreoni K; Schmitz J; Hayashi PH; Nickeleit V
    Liver Transpl; 2012 Jun; 18(6):641-58. PubMed ID: 22298469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological characterization of chronic antibody-mediated rejection in ABO-identical or ABO-compatible pediatric liver graft recipients.
    Dao M; Habès D; Taupin JL; Mussini C; Redon MJ; Suberbielle C; Jacquemin E; Gonzales E; Guettier C
    Liver Transpl; 2018 Jul; 24(7):897-907. PubMed ID: 29704327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular deposition of complement C4d is increased in liver allografts with chronic rejection.
    Martelius T; Halme L; Arola J; Höckerstedt K; Lautenschlager I
    Transpl Immunol; 2009 Sep; 21(4):244-6. PubMed ID: 19540918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
    Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies.
    Niikura T; Yamamoto I; Nakada Y; Kamejima S; Katsumata H; Yamakawa T; Furuya M; Mafune A; Kobayashi A; Tanno Y; Miki J; Yamada H; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():75-8. PubMed ID: 26031592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation.
    Haga H; Egawa H; Fujimoto Y; Ueda M; Miyagawa-Hayashino A; Sakurai T; Okuno T; Koyanagi I; Takada Y; Manabe T
    Liver Transpl; 2006 Mar; 12(3):457-64. PubMed ID: 16498648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Monitoring of Donor-specific Anti-HLA Antibodies After Intestine/Multivisceral Transplantation: Significance of De Novo Antibodies.
    Kubal C; Mangus R; Saxena R; Lobashevsky A; Higgins N; Fridell J; Tector AJ
    Transplantation; 2015 Aug; 99(8):e49-56. PubMed ID: 25769071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification.
    Mauiyyedi S; Crespo M; Collins AB; Schneeberger EE; Pascual MA; Saidman SL; Tolkoff-Rubin NE; Williams WW; Delmonico FL; Cosimi AB; Colvin RB
    J Am Soc Nephrol; 2002 Mar; 13(3):779-787. PubMed ID: 11856785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts.
    Torrealba JR; Samaniego M; Pascual J; Becker Y; Pirsch J; Sollinger H; Odorico J
    Transplantation; 2008 Dec; 86(12):1849-56. PubMed ID: 19104433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of C4d staining in ABO-identical/compatible liver transplantation.
    Sakashita H; Haga H; Ashihara E; Wen MC; Tsuji H; Miyagawa-Hayashino A; Egawa H; Takada Y; Maekawa T; Uemoto S; Manabe T
    Mod Pathol; 2007 Jun; 20(6):676-84. PubMed ID: 17431411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of C4d-negative antibody-mediated rejection in renal allografts.
    Haas M
    Curr Opin Organ Transplant; 2013 Jun; 18(3):319-26. PubMed ID: 23283250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.